GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393,775 | +25.7% | 725,924 | -5.8% | 0.00% | – |
| Q2 2023 | $1,109,151 | -31.7% | 770,244 | -0.4% | 0.00% | – |
| Q1 2023 | $1,623,537 | +86.3% | 773,113 | +0.3% | 0.00% | – |
| Q4 2022 | $871,325 | -30.5% | 771,083 | +0.2% | 0.00% | – |
| Q3 2022 | $1,253,000 | +23.3% | 769,279 | -0.8% | 0.00% | – |
| Q2 2022 | $1,016,000 | -20.8% | 775,570 | -2.7% | 0.00% | – |
| Q1 2022 | $1,283,000 | -21.9% | 796,719 | +0.5% | 0.00% | – |
| Q4 2021 | $1,642,000 | -46.3% | 793,025 | +0.7% | 0.00% | – |
| Q3 2021 | $3,056,000 | +20.3% | 787,582 | -0.8% | 0.00% | – |
| Q2 2021 | $2,540,000 | -55.3% | 793,934 | -69.7% | 0.00% | – |
| Q1 2021 | $5,687,000 | -2.3% | 2,620,626 | +0.9% | 0.00% | – |
| Q4 2020 | $5,818,000 | -13.0% | 2,598,089 | +3.8% | 0.00% | – |
| Q3 2020 | $6,684,000 | -13.1% | 2,503,111 | -0.4% | 0.00% | – |
| Q2 2020 | $7,694,000 | +53.7% | 2,514,382 | -1.5% | 0.00% | – |
| Q1 2020 | $5,005,000 | -32.3% | 2,553,541 | -1.1% | 0.00% | – |
| Q4 2019 | $7,389,000 | -12.3% | 2,583,131 | +12.5% | 0.00% | – |
| Q3 2019 | $8,429,000 | -0.7% | 2,296,925 | +12.3% | 0.00% | – |
| Q2 2019 | $8,486,000 | +179.0% | 2,045,111 | +243.4% | 0.00% | – |
| Q1 2019 | $3,042,000 | +46.7% | 595,501 | -1.5% | 0.00% | – |
| Q4 2018 | $2,073,000 | -42.7% | 604,268 | +0.4% | 0.00% | – |
| Q3 2018 | $3,616,000 | -3.4% | 601,657 | +2.3% | 0.00% | – |
| Q2 2018 | $3,742,000 | +302.4% | 588,308 | +199.9% | 0.00% | – |
| Q1 2018 | $930,000 | +40.5% | 196,157 | -1.0% | 0.00% | – |
| Q4 2017 | $662,000 | +54.3% | 198,141 | -1.1% | 0.00% | – |
| Q3 2017 | $429,000 | -14.0% | 200,378 | -1.4% | 0.00% | – |
| Q2 2017 | $499,000 | +67.4% | 203,317 | +56.8% | 0.00% | – |
| Q1 2017 | $298,000 | +4157.1% | 129,678 | +26311.0% | 0.00% | – |
| Q2 2014 | $7,000 | – | 491 | +16266.7% | 0.00% | – |
| Q1 2014 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |